Filing Details
- Accession Number:
- 0001209191-17-019981
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-10 19:57:27
- Reporting Period:
- 2017-03-10
- Filing Date:
- 2017-03-10
- Accepted Time:
- 2017-03-10 19:57:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1604464 | Atara Biotherapeutics Inc. | ATRA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1205442 | John Mcgrath | 611 Gateway Boulevard Suite 900 South San Francisco CA 94080 | Evp & Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-03-10 | 24,000 | $20.00 | 126,827 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Transaction pursuant to Rule 10b5-1 Plan adopted July 6, 2016.
Billionaire Hedge Funds
